Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 
World game at war: why some European nations have threatened a World Cup boycott 
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger 
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand 
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook 
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations 
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027 
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half 
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight 
Japan Earthquake Disrupts Auto and Chip Supply Chains 
TEANECK, N.J., April 19, 2018 -- Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the Bank of America Merrill Lynch 2018 Health Care Conference being held at the Encore Wynn, Las Vegas, Nevada.
Chairman, President and Chief Executive Officer Jack Bendheim and Chief Financial Officer Richard Johnson will address financial analysts and investors on Wednesday, May 16, 2018 at 9:20 AM PDT.
The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at http://investors.pahc.com/events. A replay of the session will be made available and archived on the company’s website.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. The company reported net sales of $764 million for the fiscal year ended June 30, 2017. Additional information about Phibro can be found by visiting www.pahc.com.
Our filings with the Securities and Exchange Commission are available online at www.sec.gov, www.pahc.com or on request from the company.
Contact:
Richard Johnson
Phibro Animal Health Corporation
Chief Financial Officer
+1-201-329-7300
[email protected]
